Topical immunotherapy: Unapproved uses, dosages, or indications

Clinics in Dermatology

Volumn 20, Issue 5, 2002, Pages 515-521

  Higgins, Elisabeth ^a   Du Vivier, Anthony ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; BLEOMYCIN; CIMETIDINE; DIPHENCYPRONE; DITHRANOL; KERATOLYTIC AGENT; PLACEBO; SQUARIC ACID DIBUTYL ESTER; TRIAZIQUONE;

ALOPECIA AREATA; AMES TEST; ANAPHYLAXIS; ARTICLE; AUTOIMMUNITY; CAUTERIZATION; CRYOTHERAPY; DERMATITIS; DRUG DOSAGE FORM; DRUG INDICATION; DRUG SAFETY; DRUG TOLERANCE; DRUG USE; ECZEMA; ERYTHEMA MULTIFORME; FEVER; FLU LIKE SYNDROME; HAZARD; HUMAN; IMMUNOTHERAPY; LASER SURGERY; LYMPHADENOPATHY; MENTAL DISEASE; PIGMENT DISORDER; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SIDE EFFECT; URTICARIA; VERRUCA VULGARIS; VITILIGO;

ADMINISTRATION, TOPICAL; ADULT; ALOPECIA AREATA; CHILD; CONTROLLED CLINICAL TRIALS; CYCLOPROPANES; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG APPROVAL; FEMALE; GREAT BRITAIN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME; WARTS;

EID: 0036757018     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(02)00272-9     Document Type: Article

References (64)

1. Mitchell A.J., Krull E.A. Alopecia areata pathogenesis and treatment . J Am Acad Dermatol. 11:1984;763-775.
2. Kano Y., Otake Y., Shiohara T. Improvement of lichen nitidus after topical dinitrochlorobenzene. J Am Acad Dermatol. 1998:1998;305-308.
3. Lewis H.M. Topical immunotherapy of refractory warts. Cutis. 12:1973;863-867.
4. Williams A.C., Klein E. Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions. Cancer. 25:1970;450-462.
5. Rhodes E.L., Dolman W., Kennedy C., Taylor R.R. Alopecia areata regrowth induced by Primula obconica. Br J Dermatol. 104:1981;339-340.
6. Helm F., Klein E., Traenkle H.L., Rivera E.P. Studies on the local administration of 2,3,5-triethylene-imino-1,4-benzoquinone(trenimom) to epitheliomas. J Invest Dermatol. 45:1965;152-159.
7. Dunaigin W.G. Use of dinitrochlorobenzene (DNCB) in therapy of warts. J Am Acad Dermatol. 10:1984;1069.
8. Happle R., Kalveram U., Büchner K., et al. Contact allergy as a therapeutic tool for alopecia areata application of squaric acid dibutylester . Dermatologica. 161:1980;289-297.
9. van der Steen P.H.M., Happle R. Topical immunotherapy of alopecia areata. Dermatol Clin. 11:1993;619-623.
10. Shapiro J. Topical immunotherapy in the treatment of chronic severe alopecia areata. Dermatol Clin. 11:1993;611-617.
11. Wilkerson M.G., Connoe T.H., Wilkin J.K. Dinitrochlorobenzene is inherently mutagenic in the presence of trace mutagenic contaminants. Arch Dermatol. 124:1988;396-398.
12. Hausen B.M., Stute J. Diphenylcyclpropenone a strong contact sensitizer . Chem Industry. 17:1980;699-700.
13. Buckley D.A., du Vivier A.W.P. The therapeutic use of topical contact sensitizers in benign dermatoses. Br J Dermatol. 145:2001;385-405.
14. Happle R., Hausen B.M., Wiesner-Menzel I. Diphencyprone in the treatment of alopecia areata. Acta Dermatovenereol (Stockholm). 63:1983;49-52.
15. MacDonald Hull S., Cunliffe W.J. Successful treatment of alopecia areata using the contact allergen diphencyprone. Br J Dermatol. 124:1991;212-213.
16. Hatzis J., Georgiotouo K., Kostakis P., et al. Treatment of alopecia areata with diphencyprone. Australas J Dermatol. 29:1988;33-35.
17. Sharma V.K., Muralidhar S. Topical immunotherapy with diphencyprone in Indians with alopecia areata. Clin Exp Dermatol. 23:1998;290-299.
18. Orecchia G., Rabbiosi G. Treatment of alopecia areata with diphencyprone. Dermatologica. 171:1985;193-196.
19. Monk B. Induction of hair growth in alopecia totalis with diphencyprone sensitization. Clin Exp Dermatol. 14:1989;154-157.
20. Ashworth J., Tuyp E. Allergic and irritant contact dermatitis compared in the treatment of alopecia totalis and universalis. Br J Dermatol. 120:1989;397-401.
21. Gordon P.M., Aldridge R.D., McVittie E., Hunter J.A.A. Topical diphencyprone for alopecia areata evaluation of 48 cases after 30 months follow-up . Br J Dermatol. 134:1996;869-871.
22. Tosti A., De Padova M.P., Minghetti G., Veronesi S. Therapies versus placebo in the treatment of patchy alopecia areata. J Am Acad Dermatol. 15:1986;209-210.
23. Hoting E., Boehm A. Therapy of alopecia areata with diphencyprone. Br J Dermatol. 127:1992;625-629.
24. Naldi L., Parazzini F., Cainelli T., Reading Group . Role of topical immunotherapy in the treatment of alopecia areata. J Am Acad Dermatol. 22:1990;654-656.
25. Rokhsar C.K., Shupack J.L., Vafai J.J., et al. Efficacy of topical sensitizers in alopecia areata. J Am Acad Dermatol. 39:1998;751-761.
26. Wiseman M.C., Shapiro J., MacDonald N., Lui H. Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol. 137:2001;1063-1068.
27. MacDonald Hull S., Wood M., Messenger A. Guidelines for the management of alopecia areata. Br J Dermatol. In press.
28. Schuttelaar M.-L.A., Hamstra J.J., Plinck E.P.B., et al. Alopecia areata in children treatment with diphencyprone . Br J Dermatol. 135:1996;581-585.
29. Weise K., Kretzschmar L., John S.M., Hamm H. Topical immunotherapy in alopecia areata anamnestic and clinical criteria of prognostic significance . Dermatology. 192:1996;129-133.
30. Happle R. Diphencyprone for the treatment of alopecia areata; more data and new aspects. [editorial] Arch Dermatol. 138:2002;112-113.
31. Valsecchi R., Cainelli T., Foiadelli L., Rossi A. Topical immunotherapy of alopecia areata a follow-up study . Acta Dermatovenereol (Stockholm). 66:1986;269-272.
32. Ochsendorf F.R., Mitrou G., Milbradt T. Therapie der Alopecia areata mit diphenylcyclopropenon. Z Hautkr. 63:1988;94-100.
33. Berth-Jones J., McBurney A., Hutchinson P.E. Diphencyprone is not detectable in serum or urine following topical application. Acta Dermatovenereol (Stockholm). 74:1994;312-313.
34. Henderson C.A., Ilchyshyn A. Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis. Br J Dermatol. 133:2002;496-497.
35. van der Steen P.H.M., Happle R. 'Dyschromia in confetti' as a side effect of topical immunotherapy with diphencyprone. Arch Dermatol. 128:1992;518-520.
36. Fernandez-Redondo V., Gomez-Centeno P., Florez A., Toribio J. Hazards in the use of diphencyprone. Allergy. 55:2000;202-203.
37. MacDonald-Hull S., Cotterill J.A.C., Norris J.F.B. Vitiligo following diphencyprone dermatitis. Br J Dermatol. 120:1989;323.
38. Sansom J.E., Molloy K.C., Lovell C.R. Occupational sensitization to diphencyprone in a chemist. Contact Derm. 32:1995;363.
39. Adisesh A., Beck M., Cherry N.M. Hazards in the use of diphencyprone. Br J Dermatol. 136:1997;465-479.
40. Bircher A.J., Bigliardi P., Langauer-Messmer S., Surber C. Occupational airborne contact dermatitis from diphencyporne in a pharmacy employee. Contact Derm. 41:1999;52.
41. Shah M., Lewis F.M., Messenger A.G. Hazards in the use of diphencyprone. Br J Dermatol. 134:2002;1153.
42. MacDonald-Hull S., Pepall L., Cunliffe W.J. Alopecia areata in children response to treatment with diphencyprone . Br J Dermatol. 125:1991;164-168.
43. Tosti A., Guidetta M.S., Bardazzi F., et al. Long term results with topical immunotherapy in children with alopecia totalis or universalis. J Am Acad Dermatol. 35:1996;199-201.
44. Schmoeckel C., Weissmann I., Plewig G., Braun-Falco O. Treatment of alopecia areata by anthralin-induced dermatitis. Arch Dermatol. 115:1979;1254-1255.
45. MacDonald-Hull S., Cunliffe W.J. Alopecia areata treated with diphencyprone is an allergic response necessary? Br J Dermatol. 122:1990;716-717.
46. Orecchia G., Perfetti L. Alopecia areata and topical sensitizers allergic response is necessary, but irritation is not . Br J Dermatol. 1999;509.
47. Happle R. Antigenic competition as a therapeutic concept for alopecia areata. Arch Dermatol Res. 267:1980;109-114.
48. Gülekon A., Gürer M.A., Bozkurt M., Keskin N. The effects of DNCB therapy on T-cell subsets of the cases with alopecia areata. Int J Dermatol. 28:1989;684-685.
49. Galbriath G.M., Pandey J.P. Tumour necrosis factor alpha (TNF-α) gene polymorphisms in alopecia areata. Hum Genet. 96:1995;433-436.
50. Tarlow J.K., Clay E.E., Cork M.J., et al. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol. 103:1994;387-390.
51. Bröcker E.-B., Echternacht-Happle K., Hamm H., Happle R. Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata modulation by topical immunotherapy . J Invest Dermatol. 88:1987;564-568.
52. Buckley D.A., Keane F.M., Munn S.E., et al. Recalcitrant viral warts treated by diphencyprone immunotherapy. Br J Dermatol. 141:1999;292-296.
53. Orecchia G., Douville H., Santagostino L., Rabbiosi G. Treatment of multiple relapsing warts with diphencyprone. Dermatologica. 1988:1988;225-231.
54. Claudy A.L., Roche H., Gogue Y. Traitement des verrues multiples et récidivantes par induction d'une hypersensibilité retardée etude critique d'utilisation du dibutylester de l'acide squarique . Ann Dermatol Vennereol. 108:1981;765-767.
55. Wiesner-Menzel L., Happle R. Ruckbildung von Plantarwartzen nach Behandlung mit Diphencyprone. Z Hautkr. 59:1984;1080-1083.
56. Rampen F.H.J., Steijlen P.M. Diphencyprone in the management of refractory palmoplantar and periungual warts. Dermatology. 193:1996;236-238.
57. Lane P.R., Hogan D.J. Diphencyprone. J Am Acad Dermatol. 19:1988;364-365.
58. Naylor M.F., Neldner K.H., Yarborough G.K., et al. Contact immunotherapy of resistant warts. J Am Acad Dermatol. 19:1988;679-683.
59. Georgala S., Danapoulou I., Katsarou A. Dinitrochlorobenzene treatment of condyloma acuminata. Australas J Dermatol. 30:1989;103-105.
60. van der Steen P., van de Kerkhof P., der Kinderen D., et al. Clinical and immunohistochemical responses of plantar warts to topical immunotherapy with diphencyprone. J Dermatol. 18:1991;330-333.
61. Eriksen K. Treatment of the common wart by induced allergic inflammation. Dermatologica. 160:1980;161-166.
62. Puig L., Alegre M., Cuatrecasas M., Moragas J.M. Erythema multiforme-like reaction following diphencyprone treatment of plane warts. Int J Dermatol. 33:1994;201-203.
63. Harland C., Saihan E.M. Regression of cutaneous metastatic malignant melanoma with topical diphencyprone and oral cimetidine. Lancet. 1989;445.
64. Traub A., Margulis S.B., Stricker R.B. Topical immunomodulation with DNCB in HIV disease a controlled trial from Brazil . Dermatology. 195:1997;369-373.